Based on the fact that PTK7 plays an important role in AML, it is interesting to investigate how it modulates the property of CML cells and whether it’s implicated in the GAS2 targeting induced CML suppression. The gene discussed is GAS2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.